ArticleHaematologica2017
Improved survival after acute graft-
Open access · goldAbstract readMulticenter Study
In one paragraph
Article in Haematologica, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed, 1 pooled it
5.9field-weighted citation impact, top 3% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
66 citing papers in PubMed, 1 synthesis or guideline pooled it, 106 citations in OpenAlex.
- Guideline
- Graft-versus-Host Disease Prophylaxis with Cyclophosphamide and Cyclosporin.The New England journal of medicine · 2025Trial
- Vedolizumab for the prevention of intestinal acute GVHD after allogeneic hematopoietic stem cell transplantation: a randomized phase 3 trial.Nature medicine · 2024Trial
- Incidence, Risk Factors for and Outcomes of Transplant-Associated Thrombotic Microangiopathy.British journal of haematology · 2020Trial
- Fecal microbiota transplantation in the treatment of acute graft-versus-host disease: A retrospective study performed by the Complications Working Party and Pediatric Diseases Working Party of the EBMT.Bone marrow transplantation · 2026Article
- Clinical Development Programme of the Innovative Mesenchymal Stromal Cell Product MSC-FFM/MC0518 for Steroid-Refractory Acute Graft-Versus-Host Disease: Design of 2 Randomised Controlled Trials in Adult and Paediatric Patients.Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie · 2026Article
- Systemic steroid treatment of grade I acute GVHD increases steroid-refractory GVHD and NRM.Blood immunology & cellular therapy · 2026Article
- Impact of acute GvHD severity on survival and disease relapse in pediatric patients undergoing allogeneic stem cell transplantation for acute lymphoblastic leukemia: an analysis based on the EBMT-PDWP registry.Bone marrow transplantation · 2026Article
- Letermovir improves the outcome of allogenic stem cell transplantation with anti-thymocyte globulin against acute leukemia and myelodysplastic syndromes.Annals of hematology · 2026Article
- Impact of age on graft-versus-host disease and overall survival in pediatric hematopoietic cell transplant recipients.Blood advances · 2026Article
- Refinement of day 28 treatment response criteria for acute GVHD: a collaboration study of the JSTCT and MAGIC.Blood advances · 2025Article
- Article
- Mass Cytometry Immunophenotyping of Graft-Conditioned Cells Following Major Histocompatibility Complex Mismatched Murine Allograft.Methods in molecular biology (Clifton, N.J.) · 2025Article
- Flow Cytometry Analysis of Graft Conditioning on the T-Cell Response in Graft-Versus-Host Disease Following Murine Allogeneic Transplantation.Methods in molecular biology (Clifton, N.J.) · 2025Article
- Endotheliopathy syndromes, TA-TMA, and SOS, are risk factors for morbidity and mortality in critically ill pediatric hematopoietic cell transplant recipients.Frontiers in oncology · 2025Article
- Targeting Intestinal Permeability for Graft-versus-Host Disease Treatment: A Therapeutic Perspective with Defibrotide.Journal of experimental pharmacology · 2025Article
- A retrospective study on beta-blocker use and outcomes in hematopoietic stem cell transplant patients.PeerJ · 2025Article
- A higher ratio of IL-2/IL-4 may be an early predictor of acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.Frontiers in immunology · 2025Article
- Identification and validation of tissue-based gene biomarkers for acute intestinal graft-versus-host disease(AIGVHD).Frontiers in immunology · 2025Article
- Is Contrast-Enhanced Ultrasonography a New, Reliable Tool for Early-Graft-versus-Host Disease Diagnosis?Journal of clinical medicine · 2024Review
6 more citing papers are in PubMed but not listed here.
Corrections and comments
- Commented on by
Authors and funding
47 authors at 20 institutions in 7 countries.
Hanna J KhouryDepartment of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA, USA.
Tao WangCIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
Michael T HemmerCIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
Daniel CourielUtah Blood and Marrow Transplant Program-Adults, Salt Lake City, UT, USA.
Amin AlousiDepartment of Stem Cell Transplantation, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Corey CutlerCenter for Hematologic Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Mahmoud AljurfDepartment of Pediatric Hematology Oncology, King Faisal Specialist Hospital Center & Research, Riyadh, Saudi Arabia.
Joseph H AntinCenter for Hematologic Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Mouhab AyasDepartment of Pediatric Hematology Oncology, King Faisal Specialist Hospital Center & Research, Riyadh, Saudi Arabia.
Minoo BattiwallaHematology Branch, National Heart, Lung and Blood Institute-NIH, Bethesda, MD, USA.
Jean-Yves CahnDepartment of Hematology, University Hospital, Grenoble, France.
Mitchell CairoDivision of Pediatric Hematology, Oncology and Stem Cell Transplantation, Department of Pediatrics, New York Medical College, Valhalla, NY, USA.
Yi-Bin ChenDivision of Hematology/Oncology, Massachusetts General Hospital, Boston, MA, USA.
Robert Peter GaleHematology Research Centre, Division of Experimental Medicine, Department of Medicine, Imperial College London, UK.
Shahrukh HashmiDepartment of Internal Medicine, Mayo Clinic Rochester, MN, USA.
Robert J HayashiDivision of Pediatric Hematology/Oncology, Department of Pediatrics, Washington University School of Medicine in St. Louis, MO, USA.
Madan JagasiaDivision of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN, USA.
Mark JuckettDivision of Hematology/Oncology/Bone Marrow Transplantation, Department of Medicine, University of Wisconsin Hospital and Clinics, Madison, WI, USA.
Rammurti T KambleDivision of Hematology and Oncology, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX, USA.
Mohamed Kharfan-DabajaDepartment of Blood and Marrow Transplantation, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
Mark LitzowDepartment of Internal Medicine, Mayo Clinic Rochester, MN, USA.
Navneet MajhailBlood & Marrow Transplant Program, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA.
Alan MillerDivision of Hematology and Oncology, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX, USA.
Taiga NishihoriDepartment of Blood and Marrow Transplantation, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
Muna QayedDepartment of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.
Helene SchoemansUniversity Hospital of Leuven, Belgium.
Harry C SchoutenDepartment of Hematology, Academische Ziekenhuis, Maastricht, the Netherlands.
Gerard SocieDepartment of Hematology, Hopital Saint Louis, Paris, France.
Jan StorekDepartment of Medicine, University of Calgary, AB, Canada.
Leo VerdonckIsala Clinics Zwolle, the Netherlands.
Ravi VijDivision of Hematology and Oncology, Washington University School of Medicine, St. Louis, MO, USA.
William A WoodDivision of Hematology/Oncology, Department of Medicine, University of North Carolina, Chapel Hill, NC, USA.
Lolie YuDivision of Hematology/Oncology & HSCT, The Center for Cancer and Blood Disorders, Children's Hospital/Louisiana State University Medical Center, New Orleans, LA, USA.
Rodrigo MartinoDivision of Clinical Hematology, Hospital de la Santa Creu I Sant Pau, Barcelona, Spain.
Matthew CarabasiThomas Jefferson University Hospital, Philadelphia, PA, USA.
Christopher DandoyCincinnati Children's Hospital Medical Center, OH, USA.
Usama GergisHematologic Malignancies & Bone Marrow Transplant, Department of Medical Oncology, New York Presbyterian Hospital/Weill Cornell Medical Center, NY, USA.
Peiman HemattiDivision of Hematology/Oncology/Bone Marrow Transplantation, Department of Medicine, University of Wisconsin Hospital and Clinics, Madison, WI, USA.
Melham SolhThe Blood and Marrow Transplant Group of Georgia, Northside Hospital, Atlanta, GA, USA.
Kareem JamaniDepartment of Medicine, University of Calgary, AB, Canada.
Leslie LehmannDana Farber Cancer Institute/Boston Children's Hospital, MA, USA.
Bipin SavaniDivision of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN, USA.
Kirk R SchultzDepartment of Pediatric Hematology, Oncology and Bone Marrow Transplant, British Columbia's Children's Hospital, The University of British Columbia, Vancouver, BC, Canada.
Baldeep M WirkDivision of Bone Marrow Transplant, Seattle Cancer Care Alliance, WA, USA.
Stephen SpellmanCIBMTR (Center for International Blood and Marrow Transplant Research), National Marrow Donor Program/Be the Match, Minneapolis, MN, USA.
Mukta AroraDivision of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota Medical Center, Minneapolis, MN, USA.
Joseph PidalaDepartment of Blood and Marrow Transplantation, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA joseph.pidala@moffitt.org.
Dana-Farber Cancer Institute · USKing Faisal Specialist Hospital & Research Centre · SAMoffitt Cancer Center · USBaylor College of Medicine · USEmory University · USMedical College of Wisconsin · USUniversity of Calgary · CAUW Health University Hospital · USVanderbilt University Medical Center · USWashington University in St. Louis · USCenter for Cancer and Blood Disorders · USCincinnati Children's Hospital Medical Center · USCleveland Clinic · USHôpital Saint-Louis · FRHospital de Sant Pau · ESImperial College London · GBIsala · NLMassachusetts General Hospital · USMayo Clinic in Arizona · USNational Heart Lung and Blood Institute · US
Funding
Data Resource for Analyzing Blood &Marrow TransplantsU24CA076518 · NCI · MEDICAL COLLEGE OF WISCONSIN · PI Amy M Moskop, Bronwen Shaw · 1998 to 2026
$105.2MImplementing a Maternal health and PRegnancy Outcomes Vision for Everyone (IMPROVE)UL1TR002378 · NCATS · EMORY UNIVERSITY · PI Andres J Garcia, Elizabeth O. Ofili · 2017 to 2026
$92.1MEasy-to-read Informed Consent for HCT Clinical TrialsU10HL069294 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI HOROWITZ, MARY MARESCA · 2011 to 2016
$43.8MInstitutional Career Development CoreKL2TR002381 · NCATS · EMORY UNIVERSITY · PI HENRY M BLUMBERG, Anandi Nayan Sheth · 2017 to 2026
$14.1MNCATS NIH HHS KL2 TR002381NCATS NIH HHS UL1 TR002378NCI NIH HHS U24 CA076518NHLBI NIH HHS U10 HL069294
Abstract
A cute graft-
Indexed as
Acute DiseaseAdolescentAdultAgedBlood DonorsChildChild, PreschoolDisease-Free SurvivalFemaleGraft vs Host DiseaseHematopoietic Stem Cell TransplantationHumansInfantLeukemia, MyeloidMaleMiddle Aged
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.